Neogap Therapeutics

Neogap secures SEK 87 million to advance clinical development of its personalised immunotherapy

11 February 2026 -- Solna, Sweden -- Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, has raised SEK 87 million in a financing round led by Sciety. The capital will be used to advance the company’s ongoing clinical study and to build the data required for the next stage of...
Stiftelsen Cancercentrum Karolinska (CCK) Visionsgatan 56 171 64 Solna, Sweden